investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Barnett & Company, Inc. Q3 2022 vs. Q4 2022 13F Holdings Comparison

Ava Hoppe | 29 April, 2023

The past few months have seen some significant changes in the holdings of Barnett & Company, Inc., a firm that manages investments for individuals and institutions alike. The Q3 2022 vs. Q4 2022 13F Holdings Comparison report shows both an increase and decrease in the shares the company holds in various issuers.

UNUM GROUP, THERMO FISHER SCIENTIFIC INC, ABBVIE INC, and TRITON INTL LTD are among the companies that saw an increase in shares held. On the other hand, CVS HEALTH CORP, GENERAL MTRS CO, H&R BLOCK INC, and POSTAL REALTY TRUST INC all saw a decrease in the shares held.

Let's take a closer look at some of these changes and what they could mean for investors.

UNUM GROUP

UNUM GROUP's shares increased by 6.6% during Q4 2022, with Barnett & Company, Inc. now holding 167200 shares. UNUM is a provider of disability income protection, life insurance, and other related products. The company has been performing well, with a net income of $279.4 million in Q3 2022, an increase of 19.6% compared to the same period last year.

THERMO FISHER SCIENTIFIC INC

Barnett & Company, Inc. held the same number of shares in THERMO FISHER SCIENTIFIC INC from Q3 to Q4 2022. The company supplies scientific research products and services, and its Q3 2022 revenue was $9.32 billion, up 25.2% year-over-year. With THERMO's focus on life sciences, diagnostics, and applied markets, it has been well-positioned to benefit from the ongoing health crisis.

ABBVIE INC

ABBVIE INC, a pharmaceutical company, saw an increase of 21.5% in shares held by Barnett & Company, Inc. during Q4 2022. The company's Q3 2022 revenue was $15.1 billion, an increase of 17.3% compared to the same period last year. The growth can be attributed to the strong sales of its products, such as Botox and Imbruvica.

CVS HEALTH CORP

CVS HEALTH CORP saw a decrease of 4.3% in shares held by Barnett & Company, Inc. during Q4 2022. CVS' Q3 2022 revenue was $79.6 billion, up 5.8% compared to the same period in the previous year. Despite this increase, the company missed its Q2 2022 earnings estimate, which may have contributed to the decrease in shares held.

GENERAL MOTORS CO

GENERAL MOTORS CO saw a significant decrease of 17.7% in shares held by Barnett & Company, Inc. during Q4 2022. The decision to sell the shares may have been influenced by the company's Q3 2022 earnings miss. The company's Q3 2022 revenue was $32.81 billion, a 19.9% decrease compared to the previous year.

POSTAL REALTY TRUST INC

POSTAL REALTY TRUST INC also saw a major decrease of 35.1% in shares held by Barnett & Company, Inc. during Q4 2022. The company is a real estate investment trust that owns and manages properties leased to the United States Postal Service. The decision to reduce its holdings might have been influenced by the uncertainty surrounding the future of the USPS and its financial health.

Conclusion

Overall, Barnett & Company, Inc. made some significant changes in its holdings during Q4 2022. While some companies' shares were increased, others saw a decrease. These changes reflect the company's assessment of the financial performance and growth prospects of each company. Although these holdings do not guarantee returns, it is essential for investors to keep track of these reports in order to make informed investment decisions.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.